Related Experiment Video
Updated: Jul 18, 2026

Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines
Published on: July 19, 2019
Deciphering Cancer Evolution Through Genomic Profiling of Patient-Derived Xenograft Together with Matched Primary
Vipin Yadav1, Ragini Kilambi2, Archana Rastogi3
1Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, D1 Vasant Kunj, New Delhi, 110070, India.
Background:
Gallbladder cancer has a poor prognosis due to its aggressive nature and late detection. Adenosquamous subtypes are rare and poorly characterized at the molecular level. Patient-derived xenograft (PDX) models preserve tumor heterogeneity and support evolutionary studies. Longitudinal specimens-primary, metastatic, and PDX-from the same patient, combined with immunohistochemistry (IHC), allow investigation of tumor progression and cellular origin.
Methodology:
A 65-year-old woman with gallbladder cancer underwent cholecystectomy, followed by omental metastasectomy upon relapse. A single-cell suspension from the metastatic lesion was injected into NOD-SCID mice to generate a PDX model. IHC assessed marker expression in primary, metastatic, and PDX tumors. A targeted next-generation sequencing somatic panel analyzed clonal evolution.
Results:
P63 confirmed the adenosquamous subtype. The PDX model retained histopathological and marker features of the primary and metastatic tumors. Diagnostic (CK7, CK17, Muc1, Muc5AC) and prognostic markers (EpCAM, CRP, S100P, AQP1, Podoplanin) were preserved across all tumors. Genomic analysis identified KRAS (G12V) mutation as the main oncogenic driver and LRP1B (Q48R) mutation as a putative tumor suppressor retained in all tumors. The secondary tumor acquired PIK3CA (E65D) and LRP1B (G37437) mutations. The PDX gained mutations in chromatin remodeling genes ARID2, ARID1A, and BAP1. Clonal trajectory analysis identified four subclones, indicating branched and linear evolution patterns.
Conclusion:
We successfully established a PDX model of gallbladder adenosquamous carcinoma, with KRAS (G12V) identified as a potential initiating mutation, and the probable tumor-initiating cell is derived from an EpCAM-positive putative cancer stem cell. Sequential analysis revealed the emergence of resistant clones and adaptive selection of chromatin remodelers in the PDX model.
More Related Videos
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancers Originate from Somatic Mutations in a Single Cell

